Aslan Pharmaceuticals (NASDAQ:ASLN) said it is collaborating with Thermo Fisher Scientific (NYSE:TMO) to manufacture a high concentration formulation of eblasakimab for phase 3 trials.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,